2023 - Research.com Medicine in Netherlands Leader Award
His primary areas of study are Internal medicine, Endocrinology, Renal function, Kidney disease and Albuminuria. His Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus, Nephropathy and Type 2 diabetes. His biological study spans a wide range of topics, including Risk factor and Urology.
His Renal function study integrates concerns from other disciplines, such as Nephrology, Heart failure, Cardiology, Kidney and Enalapril. His Kidney disease research includes themes of Gastroenterology, Dialysis, End stage renal disease and Intensive care medicine. His Albuminuria study also includes fields such as
Dick de Zeeuw mainly investigates Internal medicine, Endocrinology, Renal function, Albuminuria and Kidney disease. His research integrates issues of Cardiology, Diabetes mellitus, Nephropathy, Type 2 diabetes and Urology in his study of Internal medicine. His Diabetes mellitus research focuses on Intensive care medicine and how it relates to Clinical trial.
His research in Urology focuses on subjects like Losartan, which are connected to Pharmacology. Dick de Zeeuw has included themes like Nephrology, Urinary system, Creatinine, Prospective cohort study and End stage renal disease in his Renal function study. His Albuminuria research integrates issues from Surgery, Urine, Microalbuminuria and Risk factor.
Dick de Zeeuw focuses on Internal medicine, Type 2 diabetes, Kidney disease, Canagliflozin and Albuminuria. The study incorporates disciplines such as Diabetes mellitus, Endocrinology, Placebo and Cardiology in addition to Internal medicine. His Type 2 diabetes research incorporates elements of Metformin, Oncology, Blood pressure, Post-hoc analysis and Hazard ratio.
His research investigates the link between Canagliflozin and topics such as Heart failure that cross with problems in Myocardial infarction. His Albuminuria research is multidisciplinary, relying on both Surgery, Cohort study, Microalbuminuria, Excretion and Surrogate endpoint. His research in Renal function intersects with topics in Biomarker, Urology, Disease, Creatinine and Prospective cohort study.
The scientist’s investigation covers issues in Internal medicine, Kidney disease, Diabetes mellitus, Type 2 diabetes and Canagliflozin. His Internal medicine research is multidisciplinary, incorporating perspectives in Empagliflozin, Placebo, Endocrinology and Cardiology. Dick de Zeeuw focuses mostly in the field of Kidney disease, narrowing it down to topics relating to Renal function and, in certain cases, Urology, Clinical trial and Randomized controlled trial.
Dick de Zeeuw combines subjects such as Cohort and MEDLINE with his study of Diabetes mellitus. His Type 2 diabetes research is multidisciplinary, incorporating elements of Creatinine, Gastroenterology and Blood pressure. His work carried out in the field of Albuminuria brings together such families of science as Surgery, Microalbuminuria and Surrogate endpoint.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY
Barry M. Brenner;Mark E. Cooper;Dick De Zeeuw;William F. Keane.
The New England Journal of Medicine (2001)
Canagliflozin and cardiovascular and renal events in type 2 diabetes
Bruce Neal;Vlado Perkovic;Vlado Perkovic;Kenneth W. Mahaffey;Dick de Zeeuw.
The New England Journal of Medicine (2017)
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Andrew S. Levey;Kai-Uwe Eckardt;Yusuke Tsukamoto;Adeera Levin.
Kidney International (2005)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint.
The New England Journal of Medicine (2019)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson.
The Lancet (2011)
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A Pfeffer;Emmanuel A. Burdmann;Chao Yin Chen;Mark E. Cooper.
The New England Journal of Medicine (2009)
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population
Hans L. Hillege;Vaclav Fidler;Gilles F.H. Diercks;Wiek H. van Gilst.
Circulation (2002)
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Hans-Henrik Parving;Hans-Henrik Parving;Barry M. Brenner;John J.V. McMurray;Dick de Zeeuw.
The New England Journal of Medicine (2012)
Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition - A patient-level meta-analysis
Tazeen H. Jafar;Paul C. Stark;Christopher H. Schmid;Marcia Landa.
Annals of Internal Medicine (2003)
Renal function, neurohormonal activation, and survival in patients with chronic heart failure
Hans L. Hillege;Armand R. J. Girbes;Pieter J. de Kam;Frans Boomsma.
Circulation (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Groningen
George Institute for Global Health (Australia)
George Institute for Global Health (UK)
University of Groningen
University Medical Center Groningen
University Medical Center Groningen
University Medical Center Groningen
Stanford University
Brigham and Women's Hospital
University Medical Center Groningen
The University of Texas at Austin
University of Salford
University of Bergen
Nagoya Institute of Technology
Walter and Eliza Hall Institute of Medical Research
Nova Southeastern University
University of Maryland Center For Environmental Sciences
University of Castilla-La Mancha
Centre national de la recherche scientifique, CNRS
Chinese Academy of Sciences
Harvard University
Medical University of Lodz
University Medical Center Groningen
Duke University
University of Naples Federico II
University of Amsterdam